Skip to content
Screener

Solventum SOLV Financing Cash Flow

Financing Cash Flow at other companies

3M logo
3MMMM
-$1.33B+24.6%
Sanara MedTech Inc. logo
Sanara MedTech Inc.SMTI
-$475.22K-104%
Cardinal Health logo
Cardinal HealthCAH
-$483M
UnitedHealth Group logo
UnitedHealth GroupUNH
-$2.99B-3,122%
DENTSPLY SIRONA logo
DENTSPLY SIRONAXRAY
-$11M
Align Technology logo
Align TechnologyALGN
-$67.45M+30.0%

Other financials

Income statement

See full
Revenue$2.2B+2.2%
Gross profit$1.3B+9.4%
Operating income$181.0M-15.4%
Net income$92.0M+2.2%
EPS (diluted)$0.53+3.9%

Balance sheet

See full
Cash & equivalents$403.0M-18.1%
Total debt$5.8B-25.9%
Total equity$4.8B+31.7%
Total assets$14.2B-5.5%

Cash flow

See full
Operating cash flow$227.0M+34.3%
CapEx$83.0M-24.5%
Free cash flow-$273.0M-241%

Valuation

See full
Market cap$15.15B+20.6%
Enterprise value$20.54B+3.3%
P/E10.6×-22.5×
P/S1.8×+0.3×

Profitability

See full
Gross margin54.7%+0.2pp
Operating margin25%+15.7pp
Net margin17.3%+12.7pp
FCF margin4.6%-13.9pp

Returns & leverage

See full
Return on equity34%+22.3pp
Debt / equity1.2×-0.9×
Current ratio-0.2×

Where this comes from

Reported directly by Solventum in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The source filing: Solventum’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:27 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001964738-26-000047
(Millions)Six months ended June 30, 2026Six months ended June 30, 2025
Net transfers from (to) 3M2(30)
Purchases of treasury stock(355)
Other — net(44)(19)
Net cash used in financing activities(350)(249)
Effect of exchange rate changes on cash and cash equivalents17
Net increase (decrease) in cash and cash equivalents(475)(268)
Cash and cash equivalents at beginning of period878762
Less: cash and cash equivalents held for sale(2)

Item 1. Financial Statements

FAQ

What is Solventum's financing cash flow?
Solventum (SOLV) reported financing cash flow of -$300M in Q2 2026.
How has Solventum's financing cash flow changed year-over-year?
Solventum's financing cash flow decreased by 172.7% year-over-year, from -$110M to -$300M.
What is the long-term trend for Solventum's financing cash flow?
Over 3 years (2022 to 2025), Solventum's financing cash flow has grown at a 27.9% compound annual growth rate (CAGR), from -$1.46B to -$3.06B.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Ask your AI about Solventum's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude